Madrigal Pharmaceuticals (MDGL) Times Interest Earned (2022 - 2025)
Historic Times Interest Earned for Madrigal Pharmaceuticals (MDGL) over the last 5 years, with Q3 2025 value amounting to -$15.3.
- Madrigal Pharmaceuticals' Times Interest Earned rose 5161.28% to -$15.3 in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.56, marking a year-over-year increase of 5147.91%. This contributed to the annual value of -$33.94 for FY2024, which is 1337.69% down from last year.
- Latest data reveals that Madrigal Pharmaceuticals reported Times Interest Earned of -$15.3 as of Q3 2025, which was up 5161.28% from -$14.46 recorded in Q2 2025.
- Madrigal Pharmaceuticals' Times Interest Earned's 5-year high stood at -$14.46 during Q2 2025, with a 5-year trough of -$90.09 in Q2 2022.
- Its 4-year average for Times Interest Earned is -$36.0, with a median of -$30.71 in 2023.
- In the last 5 years, Madrigal Pharmaceuticals' Times Interest Earned tumbled by 4918.62% in 2024 and then soared by 6747.15% in 2025.
- Over the past 4 years, Madrigal Pharmaceuticals' Times Interest Earned (Quarter) stood at -$50.71 in 2022, then skyrocketed by 41.81% to -$29.51 in 2023, then soared by 35.11% to -$19.15 in 2024, then increased by 20.11% to -$15.3 in 2025.
- Its Times Interest Earned stands at -$15.3 for Q3 2025, versus -$14.46 for Q2 2025 and -$24.06 for Q1 2025.